In December 2019, a bunch of patients with a novel coronavirus was identified in Wuhan, China. Initially, named 2019 novel coronavirus (2019-nCoV), the virus has now been named SARS-CoV-2 by the International Committee of Taxonomy of Viruses (ICTV). This virus is the causative of the coronavirus disease 2019 (COVID-19) which has brought economies to halt, and billions of people under 'lockdown'. Being highly contagious, the virus did not only spread very quickly, but also, caused thousands of deaths worldwide. While the scientific community still struggles to find a cure for the disease, research goes underway, in confirming and developing a vaccine for COVID-19, with the following considerations in mind. Specimen Considerations Diagnostic tests for SARS-CoV-2 should be conducted only under expert supervision. Samples must be collected as soon as possible once the decision has been made to go ahead with testing, regardless of the duration of symptom onset. For initial diagnostic testing for SARS-CoV-2, CDC recommends collecting and testing an upper respiratory specimen. The following are acceptable specimens:
- A nasopharyngeal (NP) specimen
- An oropharyngeal (OP) specimen
- Nasal swab
- Nasopharyngeal wash/aspirate or nasal wash/aspirate (NW)

